These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel oral anticoagulants and HIV: dabigatran use with antiretrovirals. Perram J, Joseph J, Holloway C. BMJ Case Rep; 2015 Nov 20; 2015():. PubMed ID: 26590187 [Abstract] [Full Text] [Related]
5. Very Late-Onset Dabigatran-Induced Esophageal Injury. Fujikawa K, Takasugi N, Goto T, Minatoguchi S. Can J Cardiol; 2017 Apr 20; 33(4):554.e15-554.e16. PubMed ID: 28343609 [Abstract] [Full Text] [Related]
6. Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review. Ohya Y, Makihara N, Wakisaka K, Morita T, Ago T, Kitazono T, Takaba H. J Stroke Cerebrovasc Dis; 2018 Jul 20; 27(7):e128-e131. PubMed ID: 29555397 [Abstract] [Full Text] [Related]
10. Idarucizumab for Reversal of Dabigatran Prior to Acute Surgery: A Schematic Approach Based on a Case Report. Rosenberg L, Gerstrøm G, Nybo M. Basic Clin Pharmacol Toxicol; 2017 Apr 20; 120(4):407-410. PubMed ID: 27797449 [Abstract] [Full Text] [Related]
13. Identification and management of noncompliance in atrial fibrillation patients receiving dabigatran: the role of a drug monitor. Hu YF, Liao JN, Chern CM, Weng CH, Lin YJ, Chang SL, Wu CH, Sung SH, Wang KL, Lu TM, Chao TF, Lo LW, Chung FP, Hsu LC, Chen SA. Pacing Clin Electrophysiol; 2015 Apr 20; 38(4):465-71. PubMed ID: 25601592 [Abstract] [Full Text] [Related]